Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

CNS vs HNNA vs VRTS vs GROW

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CNS
Cohen & Steers, Inc.

Asset Management

Financial ServicesNYSE • US
Market Cap$3.63B
5Y Perf.+11.9%
HNNA
Hennessy Advisors, Inc.

Asset Management

Financial ServicesNASDAQ • US
Market Cap$81M
5Y Perf.+27.5%
VRTS
Virtus Investment Partners, Inc.

Asset Management

Financial ServicesNASDAQ • US
Market Cap$949M
5Y Perf.+52.5%
GROW
U.S. Global Investors, Inc.

Asset Management - Global

Financial ServicesNASDAQ • US
Market Cap$35M
5Y Perf.+25.4%

CNS vs HNNA vs VRTS vs GROW — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CNS logoCNS
HNNA logoHNNA
VRTS logoVRTS
GROW logoGROW
IndustryAsset ManagementAsset ManagementAsset ManagementAsset Management - Global
Market Cap$3.63B$81M$949M$35M
Revenue (TTM)$517M$36M$831M$8M
Net Income (TTM)$164M$8M$138M$98K
Gross Margin46.8%70.1%74.9%41.7%
Operating Margin33.4%37.0%17.4%-35.3%
Forward P/E20.8x8.0x5.5x
Total Debt$141M$41M$2.84B$83K
Cash & Equiv.$183M$72M$477M$25M

CNS vs HNNA vs VRTS vs GROWLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CNS
HNNA
VRTS
GROW
StockMay 20May 26Return
Cohen & Steers, Inc. (CNS)100111.9+11.9%
Hennessy Advisors, … (HNNA)100127.5+27.5%
Virtus Investment P… (VRTS)100152.5+52.5%
U.S. Global Investo… (GROW)100125.4+25.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: CNS vs HNNA vs VRTS vs GROW

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CNS and HNNA are tied at the top with 2 categories each — the right choice depends on your priorities. Hennessy Advisors, Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. VRTS and GROW also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
CNS
Cohen & Steers, Inc.
The Banking Pick

CNS has the current edge in this matchup, primarily because of its strength in long-term compounding and bank quality.

  • 154.3% 10Y total return vs VRTS's 142.6%
  • NIM 2.4% vs VRTS's 0.9%
  • Efficiency ratio 0.1% vs GROW's 0.8% (lower = leaner)
  • Efficiency ratio 0.1% vs GROW's 0.8%
Best for: long-term compounding and bank quality
HNNA
Hennessy Advisors, Inc.
The Banking Pick

HNNA is the #2 pick in this set and the best alternative if growth exposure and defensive is your priority.

  • Rev growth 19.9%, EPS growth 38.0%
  • Beta 0.30, yield 5.3%, current ratio 12.72x
  • 19.9% NII/revenue growth vs GROW's -23.1%
  • Beta 0.30 vs VRTS's 1.14, lower leverage
Best for: growth exposure and defensive
VRTS
Virtus Investment Partners, Inc.
The Banking Pick

VRTS is the clearest fit if your priority is income & stability and valuation efficiency.

  • Dividend streak 7 yrs, beta 1.14, yield 6.6%
  • PEG 0.38 vs CNS's 16.52
  • Lower P/E (5.5x vs 20.8x), PEG 0.38 vs 16.52
  • 6.6% yield, 7-year raise streak, vs CNS's 3.3%
Best for: income & stability and valuation efficiency
GROW
U.S. Global Investors, Inc.
The Banking Pick

GROW is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 0.71, Low D/E 0.2%, current ratio 20.87x
  • +27.8% vs VRTS's -5.5%
Best for: sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthHNNA logoHNNA19.9% NII/revenue growth vs GROW's -23.1%
ValueVRTS logoVRTSLower P/E (5.5x vs 20.8x), PEG 0.38 vs 16.52
Quality / MarginsCNS logoCNSEfficiency ratio 0.1% vs GROW's 0.8% (lower = leaner)
Stability / SafetyHNNA logoHNNABeta 0.30 vs VRTS's 1.14, lower leverage
DividendsVRTS logoVRTS6.6% yield, 7-year raise streak, vs CNS's 3.3%
Momentum (1Y)GROW logoGROW+27.8% vs VRTS's -5.5%
Efficiency (ROA)CNS logoCNSEfficiency ratio 0.1% vs GROW's 0.8%

CNS vs HNNA vs VRTS vs GROW — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CNSCohen & Steers, Inc.
FY 2024
Open-End Investment Funds
55.7%$288M
Institutional Accounts
24.9%$129M
Closed-End Investment Funds
19.3%$100M
HNNAHennessy Advisors, Inc.
FY 2025
Investment Advice
93.3%$33M
Shareholder Service
6.7%$2M
VRTSVirtus Investment Partners, Inc.
FY 2025
Investment Management Fees
50.0%$725M
Open End Funds
19.8%$287M
Retail Separate Accounts
14.5%$210M
Institutional Accounts
11.6%$168M
Closed End Funds
4.2%$61M
GROWU.S. Global Investors, Inc.
FY 2025
Investment And Advisory Services
101.5%$8M
Administrative Service
1.5%$127,000
Investment Performance
-3.0%$-247,000

CNS vs HNNA vs VRTS vs GROW — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLVRTSLAGGINGGROW

Income & Cash Flow (Last 12 Months)

Evenly matched — HNNA and VRTS each lead in 2 of 5 comparable metrics.

VRTS is the larger business by revenue, generating $831M annually — 98.3x GROW's $8M. CNS is the more profitable business, keeping 29.2% of every revenue dollar as net income compared to GROW's -4.0%.

MetricCNS logoCNSCohen & Steers, I…HNNA logoHNNAHennessy Advisors…VRTS logoVRTSVirtus Investment…GROW logoGROWU.S. Global Inves…
RevenueTrailing 12 months$517M$36M$831M$8M
EBITDAEarnings before interest/tax$198M$11M$205M-$2M
Net IncomeAfter-tax profit$164M$8M$138M$98,000
Free Cash FlowCash after capex-$94M$10M-$67M-$235,000
Gross MarginGross profit ÷ Revenue+46.8%+70.1%+74.9%+41.7%
Operating MarginEBIT ÷ Revenue+33.4%+37.0%+17.4%-35.3%
Net MarginNet income ÷ Revenue+29.2%+28.0%+16.7%-4.0%
FCF MarginFCF ÷ Revenue+16.4%+37.6%-8.9%-9.8%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+5.2%-27.3%+10.9%
Evenly matched — HNNA and VRTS each lead in 2 of 5 comparable metrics.

Valuation Metrics

VRTS leads this category, winning 3 of 7 comparable metrics.

At 7.1x trailing earnings, VRTS trades at a 70% valuation discount to CNS's 23.9x P/E. Adjusting for growth (PEG ratio), VRTS offers better value at 0.48x vs CNS's 19.03x — a lower PEG means you pay less per unit of expected earnings growth.

MetricCNS logoCNSCohen & Steers, I…HNNA logoHNNAHennessy Advisors…VRTS logoVRTSVirtus Investment…GROW logoGROWU.S. Global Inves…
Market CapShares × price$3.6B$81M$949M$35M
Enterprise ValueMkt cap + debt − cash$3.6B$49M$3.3B$10M
Trailing P/EPrice ÷ TTM EPS23.94x8.03x7.10x-104.80x
Forward P/EPrice ÷ next-FY EPS est.20.79x5.55x
PEG RatioP/E ÷ EPS growth rate19.03x2.18x0.48x
EV / EBITDAEnterprise value multiple19.48x3.62x16.20x
Price / SalesMarket cap ÷ Revenue7.01x2.27x1.14x4.14x
Price / BookPrice ÷ Book value/share6.30x0.82x0.95x0.77x
Price / FCFMarket cap ÷ FCF42.64x6.03x
VRTS leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

CNS leads this category, winning 5 of 9 comparable metrics.

CNS delivers a 28.3% return on equity — every $100 of shareholder capital generates $28 in annual profit, vs $0 for GROW. GROW carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRTS's 2.74x. On the Piotroski fundamental quality scale (0–9), HNNA scores 7/9 vs GROW's 2/9, reflecting strong financial health.

MetricCNS logoCNSCohen & Steers, I…HNNA logoHNNAHennessy Advisors…VRTS logoVRTSVirtus Investment…GROW logoGROWU.S. Global Inves…
ROE (TTM)Return on equity+28.3%+8.5%+13.5%+0.2%
ROA (TTM)Return on assets+20.5%+5.3%+3.6%+0.2%
ROICReturn on invested capital+19.2%+7.3%+3.0%-4.7%
ROCEReturn on capital employed+22.8%+8.7%+3.7%-6.2%
Piotroski ScoreFundamental quality 0–95752
Debt / EquityFinancial leverage0.25x0.41x2.74x0.00x
Net DebtTotal debt minus cash-$42M-$32M$2.4B-$24M
Cash & Equiv.Liquid assets$183M$72M$477M$25M
Total DebtShort + long-term debt$141M$41M$2.8B$83,000
Interest CoverageEBIT ÷ Interest expense9.62x2.15x600.00x
CNS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

HNNA leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in HNNA five years ago would be worth $13,761 today (with dividends reinvested), compared to $4,143 for GROW. Over the past 12 months, GROW leads with a +27.8% total return vs VRTS's -5.5%. The 3-year compound annual growth rate (CAGR) favors HNNA at 18.6% vs VRTS's 0.0% — a key indicator of consistent wealth creation.

MetricCNS logoCNSCohen & Steers, I…HNNA logoHNNAHennessy Advisors…VRTS logoVRTSVirtus Investment…GROW logoGROWU.S. Global Inves…
YTD ReturnYear-to-date+12.9%+7.4%-9.8%+7.7%
1-Year ReturnPast 12 months-5.2%+1.2%-5.5%+27.8%
3-Year ReturnCumulative with dividends+44.3%+66.8%+0.1%+3.3%
5-Year ReturnCumulative with dividends+18.2%+37.6%-35.0%-58.6%
10-Year ReturnCumulative with dividends+154.3%-35.0%+142.6%+67.4%
CAGR (3Y)Annualised 3-year return+13.0%+18.6%+0.0%+1.1%
HNNA leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CNS and HNNA each lead in 1 of 2 comparable metrics.

HNNA is the less volatile stock with a 0.30 beta — it tends to amplify market swings less than VRTS's 1.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CNS currently trades 84.7% from its 52-week high vs VRTS's 65.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCNS logoCNSCohen & Steers, I…HNNA logoHNNAHennessy Advisors…VRTS logoVRTSVirtus Investment…GROW logoGROWU.S. Global Inves…
Beta (5Y)Sensitivity to S&P 5000.98x0.30x1.14x0.71x
52-Week HighHighest price in past year$83.99$13.19$215.06$3.65
52-Week LowLowest price in past year$58.39$8.90$121.61$2.10
% of 52W HighCurrent price vs 52-week peak+84.7%+77.3%+65.9%+71.8%
RSI (14)Momentum oscillator 0–10063.151.655.446.5
Avg Volume (50D)Average daily shares traded323K9K101K25K
Evenly matched — CNS and HNNA each lead in 1 of 2 comparable metrics.

Analyst Outlook

VRTS leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: CNS as "Sell", VRTS as "Hold". Consensus price targets imply 15.0% upside for VRTS (target: $163) vs 6.9% for CNS (target: $76). For income investors, VRTS offers the higher dividend yield at 6.58% vs CNS's 3.29%.

MetricCNS logoCNSCohen & Steers, I…HNNA logoHNNAHennessy Advisors…VRTS logoVRTSVirtus Investment…GROW logoGROWU.S. Global Inves…
Analyst RatingConsensus buy/hold/sellSellHold
Price TargetConsensus 12-month target$76.00$163.00
# AnalystsCovering analysts1311
Dividend YieldAnnual dividend ÷ price+3.3%+5.3%+6.6%+3.5%
Dividend StreakConsecutive years of raises2171
Dividend / ShareAnnual DPS$2.34$0.54$9.32$0.09
Buyback YieldShare repurchases ÷ mkt cap+0.6%+0.6%+6.3%+5.6%
VRTS leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

VRTS leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). CNS leads in 1 (Profitability & Efficiency). 2 tied.

Best OverallVirtus Investment Partners,… (VRTS)Leads 2 of 6 categories
Loading custom metrics...

CNS vs HNNA vs VRTS vs GROW: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CNS or HNNA or VRTS or GROW a better buy right now?

For growth investors, Hennessy Advisors, Inc.

(HNNA) is the stronger pick with 19. 9% revenue growth year-over-year, versus -23. 1% for U. S. Global Investors, Inc. (GROW). Virtus Investment Partners, Inc. (VRTS) offers the better valuation at 7. 1x trailing P/E (5. 5x forward), making it the more compelling value choice. Analysts rate Virtus Investment Partners, Inc. (VRTS) a "Hold" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CNS or HNNA or VRTS or GROW?

On trailing P/E, Virtus Investment Partners, Inc.

(VRTS) is the cheapest at 7. 1x versus Cohen & Steers, Inc. at 23. 9x. On forward P/E, Virtus Investment Partners, Inc. is actually cheaper at 5. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Virtus Investment Partners, Inc. wins at 0. 38x versus Cohen & Steers, Inc. 's 16. 52x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — CNS or HNNA or VRTS or GROW?

Over the past 5 years, Hennessy Advisors, Inc.

(HNNA) delivered a total return of +37. 6%, compared to -58. 6% for U. S. Global Investors, Inc. (GROW). Over 10 years, the gap is even starker: CNS returned +154. 3% versus HNNA's -35. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CNS or HNNA or VRTS or GROW?

By beta (market sensitivity over 5 years), Hennessy Advisors, Inc.

(HNNA) is the lower-risk stock at 0. 30β versus Virtus Investment Partners, Inc. 's 1. 14β — meaning VRTS is approximately 275% more volatile than HNNA relative to the S&P 500. On balance sheet safety, U. S. Global Investors, Inc. (GROW) carries a lower debt/equity ratio of 0% versus 3% for Virtus Investment Partners, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CNS or HNNA or VRTS or GROW?

By revenue growth (latest reported year), Hennessy Advisors, Inc.

(HNNA) is pulling ahead at 19. 9% versus -23. 1% for U. S. Global Investors, Inc. (GROW). On earnings-per-share growth, the picture is similar: Hennessy Advisors, Inc. grew EPS 38. 0% year-over-year, compared to -126. 6% for U. S. Global Investors, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CNS or HNNA or VRTS or GROW?

Cohen & Steers, Inc.

(CNS) is the more profitable company, earning 29. 2% net margin versus -4. 0% for U. S. Global Investors, Inc. — meaning it keeps 29. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HNNA leads at 37. 0% versus -35. 3% for GROW. At the gross margin level — before operating expenses — VRTS leads at 74. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CNS or HNNA or VRTS or GROW more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Virtus Investment Partners, Inc. (VRTS) is the more undervalued stock at a PEG of 0. 38x versus Cohen & Steers, Inc. 's 16. 52x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Virtus Investment Partners, Inc. (VRTS) trades at 5. 5x forward P/E versus 20. 8x for Cohen & Steers, Inc. — 15. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRTS: 15. 0% to $163. 00.

08

Which pays a better dividend — CNS or HNNA or VRTS or GROW?

All stocks in this comparison pay dividends.

Virtus Investment Partners, Inc. (VRTS) offers the highest yield at 6. 6%, versus 3. 3% for Cohen & Steers, Inc. (CNS).

09

Is CNS or HNNA or VRTS or GROW better for a retirement portfolio?

For long-horizon retirement investors, Hennessy Advisors, Inc.

(HNNA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 30), 5. 3% yield). Both have compounded well over 10 years (HNNA: -35. 0%, VRTS: +142. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CNS and HNNA and VRTS and GROW?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CNS is a small-cap income-oriented stock; HNNA is a small-cap high-growth stock; VRTS is a small-cap deep-value stock; GROW is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

CNS

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 17%
Run This Screen
Stocks Like

HNNA

High-Growth Quality Leader

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Net Margin > 16%
Run This Screen
Stocks Like

VRTS

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Net Margin > 9%
  • Dividend Yield > 2.6%
Run This Screen
Stocks Like

GROW

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Gross Margin > 24%
  • Dividend Yield > 1.3%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CNS and HNNA and VRTS and GROW on the metrics below

Revenue Growth>
%
(CNS: 5.7% · HNNA: 19.9%)
Net Margin>
%
(CNS: 29.2% · HNNA: 28.0%)
P/E Ratio<
x
(CNS: 23.9x · HNNA: 8.0x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.